|
|
Article: Pittsburgh Post-Gazette Business Briefs Column.
- Article from:
- Knight Ridder/Tribune Business News
- Article date:
- February 12, 2003
CopyrightCOPYRIGHT 2003 Knight-Ridder/Tribune Business News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Pittsburgh Post-Gazette Knight Ridder/Tribune Business News
Feb. 12--The story slugged PG-BIZ-BRIEFS, filed for Feb. 11 by Knight Ridder/Tribune Business News, misspelled the name of Lora Tisi, outgoing president of Bluenotes.
Please delete the original story. The corrected text follows.
Feb. 11--MYLAN COMPETITOR DROPS APPEAL: Akzo Nobel NV, the Dutch drug maker, has dropped its appeal of a Jan. 16 court decision that opens the door to generic production of Remeron, a brand name antidepressant. Both Mylan Laboratories and Israel's Teva Pharmaceutical Industries had sought permission to produce antidepressants containing Remeron's active ...